Contact number
+61 2 8272 0500Chambers Review
Jones Day's well-regarded Australian arm of its global M&A practice is acknowledged for its profile in the domestic market and prized by clients for access to the firm's international resources. It is notably active on transactions in the energy and natural resources, financial services and technology sectors, and frequently recommended for deals involving US-based participants. It leverages the firm's substantial international footprint to offer cross-border M&A expertise. Key clients include Mirae Asset Global Investments, UPL and Westpac Banking Corporation.
Work Highlights
- Jones Day advised Cardinal Health in the acquisition of smart prescription platform ScalaMed.
Strengths
Provided by Chambers
"They are always efficient with responses, with relevant skills sets in different subject matters available."
"We were very happy with their ability to pre-empt and accurately service client needs and solve problems."
"They are exceptional at handling complex issues that inevitably arise. They are proactive and commercially focused and always find a way to solve the problem while often under extremely difficult deadlines."
"They are always efficient with responses, with relevant skills sets in different subject matters available."
"We were very happy with their ability to pre-empt and accurately service client needs and solve problems."
"They are exceptional at handling complex issues that inevitably arise. They are proactive and commercially focused and always find a way to solve the problem while often under extremely difficult deadlines."
Notable Practitioners
Mark Crean leads Jones Day's Australian M&A practice from the Sydney office, acting personally on a variety of transactions, including for clients in the technology and financial services sectors, as well as for real estate funds.
"He provided good, pragmatic, and commercial advice across all the issues that we needed to consider for particular transactions."